keyword
https://read.qxmd.com/read/38731908/synergistic-effects-of-weight-loss-and-catheter-ablation-can-micrornas-serve-as-predictive-biomarkers-for-the-prevention-of-atrial-fibrillation-recurrence
#1
REVIEW
Carola Y Förster, Stephan R Künzel, Sergey Shityakov, Stavros Stavrakis
In atrial fibrillation (AF), multifactorial pathologic atrial alterations are manifested by structural and electrophysiological changes known as atrial remodeling. AF frequently develops in the context of underlying cardiac abnormalities. A critical mechanistic role played by atrial stretch is played by abnormal substrates in a number of conditions that predispose to AF, including obesity, heart failure, hypertension, and sleep apnea. The significant role of overweight and obesity in the development of AF is known; however, the differential effect of overweight, obesity, cardiovascular comorbidities, lifestyle, and other modifiable risk factors on the occurrence and recurrence of AF remains to be determined...
April 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38722388/pooled-prevalences-of-obstructive-sleep-apnea-and-heart-failure-a-systematic-review-and%C3%A2-meta-analysis
#2
REVIEW
Wisarud Prechaporn, Phasu Hantrakul, Chetta Ngamjarus, Wattana Sukeepaisarnjaroen, Kittisak Sawanyawisuth, Sittichai Khamsai
Obstructive sleep apnea (OSA) is a disease with intermittent hypoxemia during sleep. It has been shown that OSA is related to several cardiovascular diseases including heart failure. Both OSA and heart failure have a close association bidirectionally. This study aimed to estimate the pooled prevalence of OSA in patients with heart failure as well as pooled prevalence of heart failure in patients with OSA. This was a systematic review with a meta-analysis. The inclusion criteria were observational or epidemiological studies conducted in adult patients with heart failure to evaluate the prevalence of OSA and patients with OSA to evaluate the prevalence of heart failure...
May 9, 2024: Heart Failure Reviews
https://read.qxmd.com/read/38713445/comparative-evaluation-of-postoperative-outcomes-and-expenditure-between-robotic-and-conventional-single-level-lumbar-fusion-surgery-a-comprehensive-analysis-of-nationwide-inpatient-sample-data
#3
JOURNAL ARTICLE
David Maman, Assil Mahamid, Binyamin Finkel, Hadar Gan-Or, Linor Fournier, Yaron Berkovich, Eyal Behrbalk
INTRODUCTION: In this study, we investigate the evolution of lumbar fusion surgery with robotic assistance, specifically focusing on the impact of robotic technology on pedicle screw placement and fixation. Utilizing data from the Nationwide Inpatient Sample (NIS) covering 2016 to 2019, we conduct a comprehensive analysis of postoperative outcomes and costs for single-level lumbar fusion surgery. Traditionally, freehand techniques for pedicle screw placement posed risks, leading to the development of robotic-assisted techniques with advantages such as reduced misplacement, increased precision, smaller incisions, and decreased surgeon fatigue...
May 7, 2024: European Spine Journal
https://read.qxmd.com/read/38711723/ventricular-tachycardia-in-patients-with-takotsubo-cardiomyopathy-prevalence-predictors-and-associated-in-hospital-adverse-events
#4
JOURNAL ARTICLE
Omar Elkattawy, Mabad Shacker, Sedra Alabed, Daniel Elias, Sherif Elkattawy, Omar Mohamed, Charlene Mansour, Casey Hamlet, Salma Emara, Fayez Shamoon
Introduction  The purpose of this study was to determine the prevalence of ventricular tachycardia (VT) among patients admitted with takotsubo cardiomyopathy (TCM) as well as to analyze the predictors of VT and the predictors of mortality among patients admitted with TCM. Methods Data were obtained from the National Inpatient Sample (NIS) database from January 2016 to December 2019. Patients with a primary diagnosis of TCM were selected using ICD-10 code I51.81. Subsequently, the study population was divided into patients who developed VT vs...
April 2024: Curēus
https://read.qxmd.com/read/38704352/association-of-comorbid-obstructive-sleep-apnea-and-insomnia-with-risk-of-major-adverse-cardiovascular-events-in-sleep-medicine-center-patients
#5
JOURNAL ARTICLE
Faith S Luyster, Lynn M Baniak, Christopher C Imes, Bomin Jeon, Jonna L Morris, Staci Orbell, Paul Scott
OBJECTIVES: To investigate the association between comorbid obstructive sleep apnea and insomnia and major adverse cardiovascular events, including myocardial infarction, unstable angina, congestive heart failure, and stroke, in adults with suspected sleep disorders who underwent sleep apnea testing. METHODS: We conducted a retrospective analysis of electronic medical records data from patients with clinical encounters at sleep medicine centers to identify patients with comorbid obstructive sleep apnea and insomnia, obstructive sleep apnea only, insomnia only, and patients without a diagnosis of obstructive sleep apnea or insomnia (i...
May 3, 2024: Sleep Health
https://read.qxmd.com/read/38657976/prognostic-influence-of-weight-loss-on-overweight-obese-young-heart-failure-patients
#6
JOURNAL ARTICLE
Shan He, Xiaonan Guan, Jianjun Zhang
OBJECTIVES: To explore the prognostic influence of weight loss (WL) on young overweight/obesity (OW/OB) individuals with heart failure (HF). METHODS: Heart failure enrollees (younger than 45 years, body mass index [BMI] of ≥25 kg/m2 ) who received medical treatment at Beijing Chaoyang Hospital, Beijing, China, were classified into 2 groups according to whether they experienced significant WL (≥5% from baseline one year after discharge). One-year occurrence rate of major adverse cardiac events (MACEs) comprising cardiac death and rehospitalization for HF was determined...
April 2024: Saudi Medical Journal
https://read.qxmd.com/read/38646831/mortality-hospitalization-and-cardiac-interventions-in-patients-with-atrial-fibrillation-aged-65-years
#7
JOURNAL ARTICLE
Aditya Bhonsale, Jianhui Zhu, Floyd Thoma, Steve Koscumb, Krishna Kancharla, Andrew Voigt, Jared Magnani, N A Estes, Samir Saba, Oscar Marroquin, Suresh Mulukutla, Sandeep Jain
BACKGROUND: The risk factor (RF) burden, clinical course, and long-term outcome among patients with atrial fibrillation (AF) aged <65 years is unclear. METHODS: Adult (n=67 221; mean age, 72.4±12.3 years; and 45% female) patients with AF evaluated at the University of Pittsburgh Medical Center between January 2010 and December 2019 were studied. Hospital system-wide electronic health records and administrative data were utilized to ascertain RFs, comorbidities, and subsequent hospitalization and cardiac interventions...
April 22, 2024: Circulation. Arrhythmia and Electrophysiology
https://read.qxmd.com/read/38646254/ventricular-tachycardia-in-patients-with-pre-eclampsia-prevalence-predictors-and-associated-in-hospital-adverse-events
#8
JOURNAL ARTICLE
Omar Elkattawy, Keanaan Malke, David Mothy, Aaron Tran, Sherif Elkattawy, Sayeeda Rab, Ammar Zidat, Omar Mohamed, Fayez Shamoon
Introduction Pre-eclampsia is a pregnancy-associated multisystem disorder; in rare cases, it can be complicated by arrhythmias such as ventricular tachycardia (VT). The purpose of this study was to determine the prevalence and predictors of VT among patients admitted with pre-eclampsia as well as to analyze the independent association of VT with in-hospital outcomes in this population. Methods Data were obtained from the National Inpatient Sample from January 2016 to December 2019. Patients with a primary diagnosis of pre-eclampsia were selected using International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes...
March 2024: Curēus
https://read.qxmd.com/read/38605140/impact-of-renal-denervation-on-quality-of-life-how-does-renal-denervation-contribute-to-improving-hypertension-treatment-affected-by-poor-medication-adherence
#9
REVIEW
Keisuke Okamura, Hideaki Shimada, Keisuke Imazato, Hideto Sako, Akihiro Udo, Kenichiro Taniguchi, Shogo Morisaki, Ichiro Imamura, Hidenori Urata, Hisatomi Arima, Shin-Ichiro Miura
The US Food and Drug Administration has approved renal denervation (RDN) as a new treatment option for hypertension (HT) because it not only has antihypertensive effects but also improves the quality of blood pressure (BP) reduction. RDN is expected to be increasingly used in clinical practice in the future. This review summarizes the impact of RDN on quality of life (QOL). Although the treatment of HT aims to improve life prognosis, the use of antihypertensive agents can impair QOL because of adverse effects and lifestyle changes associated with long-term medication use...
April 11, 2024: Hypertension Research: Official Journal of the Japanese Society of Hypertension
https://read.qxmd.com/read/38563371/cardiovascular-risk-in-young-patients-diagnosed-with-obstructive-sleep-apnea
#10
JOURNAL ARTICLE
Ida E Albertsen, Jesper Bille, Gregory Piazza, Gregory Y H Lip, Peter B Nielsen
BACKGROUND: In older adults, obstructive sleep apnea (OSA) has been associated with several cardiovascular complications. Whether young patients diagnosed with OSA also are at higher risk of developing subsequent cardiovascular disease is uncertain. We aimed to estimate the risk of developing an incident cardiovascular event among young patients diagnosed with OSA. METHODS AND RESULTS: We linked nationwide Danish health registries to identify a cohort of patients aged ≤50 years with OSA using data from 2010 through 2018...
April 2, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38558648/frequency-of-pulmonary-hypertension-and-its-associated-risk-factors-in-end-stage-renal-disease-esrd-patients-on-maintenance-hemodialysis
#11
JOURNAL ARTICLE
Manisha Khemchandani, Kiran Nasir, Ruqaya Qureshi, Murtaza Dhrolia, Aasim Ahmad
Introduction Pulmonary hypertension (PH) is a recognized complication in patients with end-stage renal disease (ESRD undergoing maintenance hemodialysis (MHD). PH is commonly found in patients with chronic kidney disease (CKD) and ESRD. PH is associated with increased morbidity and mortality in patients with CKD. Methodology This cross-sectional study aimed to assess the prevalence of PH and its associated risk factors in MHD patients. A total of 220 ESRD patients on MHD patients at The Kidney Center, Karachi, Pakistan, aged 18-70 were included...
February 2024: Curēus
https://read.qxmd.com/read/38557651/early-recognition-and-treatment-of-osa-in-hospitalized-patients-and-its-impact-on-health-care-utilization-in-rural-population-a-real-world-study
#12
JOURNAL ARTICLE
Sunil Sharma, Robert Stansbury, Priyanka Srinivasan, Edward Rojas, Stuart F Quan, Kassandra Olgers, Scott Knollinger, Calvin Seol, Malleri Hardison, Jesse Thompson, Nickolas Hansen, Wen Sijin
STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is a highly prevalent, yet under-diagnosed condition. Due to its adverse impact on risk for cardiopulmonary disorders, there is interest in pro-active screening of OSA in hospitalized patients. We studied the long-term outcome of such screened patients who were initiated on positive airway pressure (PAP) therapy. METHODS: Hospitalized patients who screened positive for OSA and were confirmed with post-discharge polysomnography (PSG) were dichotomized by PAP adherence and followed for a period of 12 months to evaluate for the composite endpoint of hospital readmissions and emergency room (ED) visits for cardiopulmonary reasons...
April 1, 2024: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/38501519/the-cardiovascular-impact-of-obstructive-sleep-apnea-in-women-current-knowledge-and-future-perspectives
#13
REVIEW
Barbara K Parise, Naira Lapi Ferreira, Luciano F Drager
Overall, cardiovascular diseases have many sex-related differences in prevalence, clinical presentation, and outcomes. A considerable amount of evidence suggests that obstructive sleep apnea (OSA) increases the risk for several cardiovascular diseases. Only recently, the sex-related differences in cardiovascular outcomes gained interest in the literature. In this review, the authors discuss the current evidence addressing the cardiovascular impact of OSA in women. Particular attention is devoted to hypertension, target-organ damage, heart failure, atrial fibrillation, and cardiovascular events (including mortality)...
December 2023: Sleep Medicine Clinics
https://read.qxmd.com/read/38479652/sleep-apnea-the-risk-of-out-of-hospital-cardiac-arrest-and-potential-benefits-of-continuous-positive-airway-pressure-therapy-a-nationwide-study
#14
JOURNAL ARTICLE
Pelpika Qayoumi, Ruben Coronel, Fredrik Folke, Anojhaan Arulmurugananthavadivel, Saaima Parveen, Harman Yonis, Amani Meaidi, Morten Lamberts, Morten Schou, Christian Torp-Pedersen, Gunnar Hilmar Gislason, Talip E Eroglu
OBJECTIVE: Patients with sleep apnea (SA) are at increased cardiovascular risk. However, little is known about the risk of out-of-hospital cardiac arrest (OHCA) in patients with SA. Therefore, we studied the relation between SA patients who did and did not receive continuous positive airway pressure (CPAP) therapy with OHCA in the general population. METHODS: Using nationwide databases, we conducted a nested case-control study with OHCA-cases of presumed cardiac causes and age/sex/OHCA-date matched non-OHCA-controls from the general population...
March 11, 2024: Resuscitation
https://read.qxmd.com/read/38472700/pulmonary-hypertension-in-newly-diagnosed-obstructive-sleep-apnea-chronic-obstructive-pulmonary-disease-overlap-syndrome-patients-attending-a-tertiary-care-centre-a-cross-sectional-analysis
#15
JOURNAL ARTICLE
Jyothi Reshma S, Sunny George, Santhosh Kumar P
INTRODUCTION: Overlap syndrome is the association of obstructive sleep apnea (OSA) with chronic obstructive pulmonary disorder and with other chronic respiratory diseases. Patients with overlap syndrome have a worse prognosis compared with chronic obstructive pulmonary disorder or OSA alone. Additionally, patients with combined chronic obstructive pulmonary disorder and OSA are more likely to develop pulmonary hypertension and right heart failure much earlier than those without overlap...
March 12, 2024: Irish Journal of Medical Science
https://read.qxmd.com/read/38452996/achieving-consensus-severity-graded-definitions-of-fontan-associated-complications-to-characterize-fontan-circulatory-failure
#16
JOURNAL ARTICLE
Kurt R Schumacher, Ari Cedars, Kiona Allen, David Goldberg, Adrianna Batazzi, Garrett Reichle, Frank DiPaola, David Selewski, Melissa Cousino, David N Rosenthal
BACKGROUND: Fontan physiology leads to chronic changes in other organ systems that may affect long-term survival and the success of heart transplantation. Inadequate assessment and treatment of the extra-cardiac effects of Fontan may contribute to poor outcomes. Severity graded/ordinal consensus definitions of Fontan complications are lacking which limits understanding of how Fontan-specific morbidity affects patient outcomes. METHODS AND RESULTS: A panel of Fontan patient and physiology experts, including pediatric, adult congenital, heart failure, and critical care cardiology, and pediatric nephrology, hepatology and psychology, convened to develop definitions of Fontan complications...
March 5, 2024: Journal of Cardiac Failure
https://read.qxmd.com/read/38410942/association-of-sex-with-cardiovascular-outcomes-in-heart-failure-patients-with-obstructive-or-central-sleep-apnea
#17
JOURNAL ARTICLE
Boping Huang, Yan Huang, Mei Zhai, Qiong Zhou, Shiming Ji, Huihui Liu, Xiaofeng Zhuang, Yuhui Zhang, Jian Zhang
BACKGROUND: This study investigated the association of sex with cardiovascular outcomes in a prospective cohort of patients with heart failure (HF) with obstructive sleep apnea or central sleep apnea. METHODS AND RESULTS: Patients were screened for sleep apnea on admission using multichannel cardiopulmonary monitoring from May 2015 to July 2018. The primary outcome was a composite of cardiovascular death or unplanned hospitalization for worsening HF. Ultimately, 453 patients with HF with obstructive sleep apnea or central sleep apnea were included; 71 (15...
February 27, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38410033/sleep-apnea-in-patients-undergoing-coronary-artery-bypass-grafting-impact-on-perioperative-outcomes
#18
JOURNAL ARTICLE
Kassar Farha, Mustafa Gercek, Muhammed Gercek, Johannes Mischlinger, Volker Rudolph, Jan F Gummert, Charbel Saad, Anas Aboud, Henrik Fox
Sleep-disordered breathing is common in patients with coronary artery disease undergoing coronary artery bypass grafting. Sleep-disordered breathing is associated with increased perioperative morbidity, arrhythmias (e.g. atrial fibrillation) and mortality. This study investigated the impact of sleep-disordered breathing on the postoperative course after coronary artery bypass grafting, including development of atrial fibrillation. This prospective single-centre cohort study included adults undergoing coronary artery bypass grafting...
February 26, 2024: Journal of Sleep Research
https://read.qxmd.com/read/38403592/unraveling-the-causality-between-chronic-obstructive-pulmonary-disease-and-its-common-comorbidities-using-bidirectional-mendelian-randomization
#19
JOURNAL ARTICLE
Zihan Wang, Yongchang Sun
BACKGROUND: Chronic obstructive pulmonary disease (COPD) frequently coexists with various diseases, yet the causal relationship between COPD and these comorbidities remains ambiguous. As a result, the aim of our study is to elucidate the potential causality between COPD and its common comorbidities. METHODS: We employed the Mendelian randomization (MR) method to analyze single nucleotide polymorphism (SNP) data of common comorbidities with COPD from FinnGen and Integrative Epidemiology Unit (IEU) databases...
February 26, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38386021/dahos-study-efficacy-of-dapagliflozin-in-treating-heart-failure-with-reduced-ejection-fraction-and-obstructive-sleep-apnea-syndrome-a-3-month-multicenter-randomized-controlled-clinical-trial
#20
JOURNAL ARTICLE
Liang Xie, Shengnan Li, Xiaojin Yu, Qin Wei, Fuchao Yu, Jiayi Tong
BACKGROUND: The recent discovery of new therapeutic approaches to heart failure with reduced ejection fraction (HFrEF), including sodium-glucose cotransporter-2 (SGLT-2) inhibitors, as well as improved treatment of co-morbidities has provided much needed help to HFrEF. In addition, dapagliflozin, one of the SGLT-2 inhibitors, serves as a promising candidate in treating obstructive sleep apnea (OSA) of HFrEF patients due to its likely mechanism of countering the pathophysiology of OSA of HFrEF...
February 22, 2024: European Journal of Clinical Pharmacology
keyword
keyword
47961
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.